Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease

Surbhi Sidana, MD, David L Murray, MD PhD, Surendra Dasari, PhD, Ronald S. Go, MD, Maria Alice Willrich, PhD, Melissa Snyder, PhD, Mindy Kohlhagen, John A. Lust, MD PhD, Eli Muchtar, MD, Taxiarchis Kourelis, MD, Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD

Blood (2019) 134 (Supplement_1): 3510.

https://doi.org/10.1182/blood-2019-121712

Published: 2019

Journal Articles

Prostaglandin I 2 in the Endosteal Bone Marrow Niche As a Novel Regulator of Hematopoietic Stem Cells

Joshua Tay, PhD, Jean-Pierre Levesque, PhD, Falak Helwani, PhD, Gareth Price, PhD, Bianca Nowlan, Masters, Valerie Barbier, Masters, Ingrid G Winkler, PhD

Blood (2018) 132 (Supplement 1): 2575.

https://doi.org/10.1182/blood-2018-99-115869

Published: 2018

Journal Articles

Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 1435.

https://doi.org/10.1182/blood-2018-99-118764

Published: 2018

Journal Articles

Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis

Jean-Jacques Kiladjian, MD PhD, Juliette Soret-Dulphy, MD, Matthieu Resche-Rigon, MD PhD, Francoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Valérie Rolland-Neyret, Claude Capron, Sylvie Chevret, MD PhD, Stephane Giraudier, MD PhD, Bruno Cassinat, PharmD, PhD

Blood (2018) 132 (Supplement 1): 581.

https://doi.org/10.1182/blood-2018-99-110785

Published: 2018

Journal Articles

Evaluating the Clinical Utility of Testing for Autoimmune Disorders in the Setting of Leukopenia/Neutropenia in an Ambulatory Hematology Clinic.

Devin Malik, MD, Philip Kuriakose, MD, Joyce Philip, MD, Amal Hejab, MD, Alexander Horbal, DO, Vivek Mendiratta, MD

Blood (2017) 130 (Supplement 1): 1000.

https://doi.org/10.1182/blood.V130.Suppl_1.1000.1000

Published: 2017

Journal Articles

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Bilawal Ahmed, MD, Beenish Zulfiqar, MD

Blood (2017) 130 (Supplement 1): 4757.

https://doi.org/10.1182/blood.V130.Suppl_1.4757.4757

Published: 2017

Journal Articles

Low-Dose Second Generation TKI Is an Effective Approach to Reduce TKI Related Side Effects and Toxicity While Preserving Molecular Response in CML Patients with TKI Intolerance

Varun Mehra, MRCP, FRCPath, Titilola Oyebamiji, Stefanie Widya, Robin M. Ireland, FRCP, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Kavita Raj, MD PhD, Donal McLornan, Judith Marsh, MD, Victoria Potter, Joanna Large, Isabel Duggins, Aytug Kizilors, PhD, Nicholas Lea, PhD, Antonio Pagliuca, MD, Ghulam Mufti, DM, FRCP, FRCPath, Hugues De Lavallade

Blood (2017) 130 (Supplement 1): 5250.

https://doi.org/10.1182/blood.V130.Suppl_1.5250.5250

Published: 2017

Journal Articles

Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?

Maria Carolina Oliveira, MD PhD, Myriam Labopin, MD, Jörg Henes, MD PhD, John Moore, MD, Nicoletta Del Papa, MD PhD, Ricca Stanciu, Ioanna Sakellari, MD PhD, Roland Schroers, MD, Hans Ulrich Scherer, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof., Thomas Daikeler, MD, Tobias Alexander, Jürgen Finke, MD, Manuela Badoglio, John A Snowden, MD FRCP, FRCPath, Dominique Farge, MD PhD

Blood (2014) 124 (21): 2517.

https://doi.org/10.1182/blood.V124.21.2517.2517

Published: 2014

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

Journal Articles

Lamarque M, Raynaud S, Itzykson R, et al. The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience. Blood . 2012;120(25): 5084-5085 .

Blood (2014) 123 (26): 4152.

https://doi.org/10.1182/blood-2014-04-571323

Published: 2014

Journal Articles

Patterns Of Non-Hematological Adverse Effects In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Treated With Ponatinib – Experience At a Single Institution

Preetesh Jain, MD, DM, PhD, Hagop M. Kantarjian, MD, Carlos Guillermo Romo, MD, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Marylou Cardenas-Turanzas, MD, Dr PH, Sherry Pierce, Mary Joy Liboon, Evguenia Gachimova, Tapan M. Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Susan O'Brien, MD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 4019.

https://doi.org/10.1182/blood.V122.21.4019.4019

Published: 2013

Journal Articles

Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736,

Andrew S. Moore, MBBS, FRACP, Amir Faisal, Vassilios Bavetsias, David Gonzalez de Castro, PhD, Chongbo Sun, Butrus Atrash, Melanie Valenti, Alexis de Haven Brandon, Sian Avery, Andrew DJ Pearson, Paul Workman, Julian Blagg, Florence I Raynaud, Suzanne A Eccles, Spiros Linardopoulos

Blood (2011) 118 (21): 3492.

https://doi.org/10.1182/blood.V118.21.3492.3492

Published: 2011

Journal Articles

Combination Treatment of Essential Thrombocythemia with Hydroxyurea and Anagrelide

Inhye E. Ahn, MD, Ethan A. Natelson, MD, Lawrence Rice, MD

Blood (2011) 118 (21): 5177.

https://doi.org/10.1182/blood.V118.21.5177.5177

Published: 2011

Journal Articles

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Jan Storek, MD, PhD, Rob Woolson, MS, Paul K. Wallace, MS, PhD, Gregory Sempowski, MD, Peter A. McSweeney, MD, Maureen Mayes, MD, Leslie Crofford, MD, Sharon LeClercq, MD, Richard A. Nash, MD, Keith M. Sullivan, MD

Blood (2011) 118 (21): 4917.

https://doi.org/10.1182/blood.V118.21.4917.4917

Published: 2011

Journal Articles

Correlation Between Outcome and Genetic Abnormalities Identified by High-Density Single Nucleotide Polymorphism Array Analysis In Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia with Multi-Lineage Dysplasia Treated with Azacitidine

Thomas Cluzeau, Chimène Moreilhon, Nicolas Mounier, Jean-Michel Karsenti, Lionel Mannone, Henri Vinti, Laurence Legros, MD, Antoine Thyss, Georges Garnier, Jean Gutnecht, Daniel Re, MD, Patrick Auberger, Jill-Patrice Cassuto, S. Dominique Raynaud, MD

Blood (2010) 116 (21): 2929.

https://doi.org/10.1182/blood.V116.21.2929.2929

Published: 2010

Journal Articles

Association of Hodgkin Lymphoma and Non-Hodgkin Lymphoma In the Same Patient. Clinicopathologic Characteristics and Outcome In a Series of 20 Cases

Stefano Fogazzi, Alessandra Tucci, Chiara Bottelli, Marco Ungari, Fabio Facchetti, Giuseppe Rossi, MD

Blood (2010) 116 (21): 3886.

https://doi.org/10.1182/blood.V116.21.3886.3886

Published: 2010

Journal Articles

Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3 -ITD Positive AML In Vitro and In Vivo

Andrew S Moore, Amir Faisal, Vassilios Bavetsias, Chongbo Sun, Butrus Atrash, Melanie Valenti, Alexis de Haven Brandon, Sian Avery, Florence I Raynaud, Paul Workman, Andrew DJ Pearson, Julian Blagg, Suzanne A Eccles, Spiros Linardopoulos

Blood (2010) 116 (21): 3289.

https://doi.org/10.1182/blood.V116.21.3289.3289

Published: 2010

Journal Articles

Induction of Autophagic Cell Death Circumvents Azacitidine-Resistance In Myelodysplastic Syndrome-Derived Cell Lines

Thomas Cluzeau, Guillaume Robert, Jean-Michel Karsenti, Frederic Luciano, Alexandre Puissant, S. Dominique Raynaud, MD, Lionel Mannone, Jill-Patrice Cassuto, Nicolas Mounier, Patrick Auberger

Blood (2010) 116 (21): 1817.

https://doi.org/10.1182/blood.V116.21.1817.1817

Published: 2010

Journal Articles

Immunological and Hematological Findings Associated with Thymic Epithelial Neoplasms

Muhammad Rizwan Khawaja, MD, Nicholas J Miller, BS, Patrick J Loehrer, Sr, MD, Robert P. Nelson, Jr, MD

Blood (2010) 116 (21): 1742.

https://doi.org/10.1182/blood.V116.21.1742.1742

Published: 2010

Journal Articles

Spontaneous Tumoural Regression in a Patient with t(4;14) Translocation Multiple Myeloma. A Case Report.

Noemi Puig, MD, Christine Chen, MD, Joseph Mikhael, MD, Donna Reece, MD, Suzanne Trudel, MD, Vishal Kukreti, MD

Blood (2007) 110 (11): 4777.

https://doi.org/10.1182/blood.V110.11.4777.4777

Published: 2007

NARROW

Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease

Prostaglandin I 2 in the Endosteal Bone Marrow Niche As a Novel Regulator of Hematopoietic Stem Cells

Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia

Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis

Evaluating the Clinical Utility of Testing for Autoimmune Disorders in the Setting of Leukopenia/Neutropenia in an Ambulatory Hematology Clinic.

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Low-Dose Second Generation TKI Is an Effective Approach to Reduce TKI Related Side Effects and Toxicity While Preserving Molecular Response in CML Patients with TKI Intolerance

Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Lamarque M, Raynaud S, Itzykson R, et al. The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience. Blood . 2012;120(25): 5084-5085 .

Patterns Of Non-Hematological Adverse Effects In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Treated With Ponatinib – Experience At a Single Institution

Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736,

Combination Treatment of Essential Thrombocythemia with Hydroxyurea and Anagrelide

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Correlation Between Outcome and Genetic Abnormalities Identified by High-Density Single Nucleotide Polymorphism Array Analysis In Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia with Multi-Lineage Dysplasia Treated with Azacitidine

Association of Hodgkin Lymphoma and Non-Hodgkin Lymphoma In the Same Patient. Clinicopathologic Characteristics and Outcome In a Series of 20 Cases

Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3 -ITD Positive AML In Vitro and In Vivo

Induction of Autophagic Cell Death Circumvents Azacitidine-Resistance In Myelodysplastic Syndrome-Derived Cell Lines

Immunological and Hematological Findings Associated with Thymic Epithelial Neoplasms

Spontaneous Tumoural Regression in a Patient with t(4;14) Translocation Multiple Myeloma. A Case Report.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only